ÂÜÀòÂÒÂ×

Hong Zebger-Gong possesses extensive experience in oncology clinical development and safety, currently serving as Senior Medical Director for Global Oncology Clinical Development and Oncology Clinical Safety at Daiichi Sankyo, Inc. Prior roles include Global Safety Leader in Oncology at Bayer Pharmaceuticals and Medical Director for Oncology Clinical Development at PAREXEL International. Hong's academic background includes a Doctor of Medicine (focused on Oncology) from the University of Duisburg-Essen and a postgraduate fellowship in Pathology from Tufts University School of Medicine. Additional experience includes serving as a Senior Researcher/Physician and Group Leader at Charité - Universitätsmedizin Berlin, and as an Assistant Professor at Aarhus University.